Do Platelet Function Analyzer-100 testing results correlate with bleeding events after percutaneous renal biopsy?

Clinical Nephrology

Volumn 73, Issue 3, 2010, Pages 229-237

  Islam, N ^a   Fulop, T ^a   Zsom, L ^a   Miller, E ^b   Mire, C D ^c   LeBrun, C J ^d   Schmidt, D W ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Southwest Mississippi Nephrology   (United States)

^c Nephrology Associates   (United States)

^d Nephrology Associates   (United States)

Author keywords

Bleeding (complications); Kidney biopsy; PFA 100; Platelet function testing; Renal failure

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; CREATININE; DESMOPRESSIN ACETATE; ELECTROLYTE; NITROGEN; UREA;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD ANALYSIS; BLOOD CELL COUNT; BLOOD CLOTTING TEST; BLOOD PRESSURE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOMA; HEMATURIA; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PATIENT CARE; PERCUTANEOUS BIOPSY; PROTHROMBIN TIME; REAL TIME ECHOGRAPHY; THROMBOCYTE FUNCTION; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

EID: 77649256769     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP73229     Document Type: Article

References (21)

1. Weigert AL, Schafer AI. Uremic bleeding: pathogenesis and therapy. Am J Med Sci. 1998; 316: 94-104.
2. Shidham GB, Siddiqi N, Beres JA, Logan B, Nagaraja HN, Shidham SG, Piering WF. Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology. 2005; 10: 305-310.
3. Zupan IP, Sabovic M, Salobir B, Ponikvar JB, Cernelc P. Utility of in vitro closure time test for evaluating platelet-related primary hemostasis in dialysis patients. Am J Kidney Dis. 2003; 42: 746-751.
4. Escolar G, Cases A, Bastida E, Garrido M, Lopez J, Revert L, Castillo R, Ordinas A. Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb - IIIa. Blood. 1990; 76:1331-1340.
5. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost. 1990; 16: 1-20.
6. Mammen EF, Comp PC, Gosselin R, Greenberg C, Hoots WK, Kessler CM, Larkin EC, Liles D, Nugent DJ. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost. 1998; 24: 195-202.
7. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function analyzer - PFA-100. Semin Thromb Hemost. 1995; 21 (Suppl 2): 106-112.
8. Harrison P, Robinson MS, Mackie IJ, Joseph J, McDonald SJ, Liesner R, Savidge GF, Pasi J, Machin SJ. Performance of the platelet function analyzer PFA-100 in testing abnormalities of primary haemostasis. Blood Coagul Fibrinolysis. 1999; 10: 25-31.
9. Haubelt H, Anders C, Vogt A, Hoerdt P, Seyfert UT, Hellstern P. Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals Br J Haematol. 2005; 130: 759-767.
10. Fressinaud E, Veyradier A, Sigaud M, Boyer-Neumann C, Le Boterff C, Meyer D. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyzer at high shear rates. Br J Haematol. 1999; 106: 777-783.
11. Zeigler ZR, Megaludis A, Fraley DS. Desmopressin (d-DAVP) effects on platelet rheology and von Willebrand factor activities in uremia. Am J Hematol. 1992; 39: 90-95.
12. Zupan IP, Sabovic M, Salobir B, Ponikvar JB, Cernelc P, Lavre J, Vujkovac B. The study of anaemia-related haemostasis impairment in haemodialysis patients by in vitro closure time test. Thromb Haemost. 2005; 93: 375-379.
13. Tang S, Li JH, Lui SL, Chan TM, Cheng IK, Lai KN. Free-hand, ultrasound-guided percutaneous renal biopsy: experience from a single operator. Eur J Radiol. 2002; 41: 65-69.
14. Manno C, Strippoli GF, Arnesano L, Bonifati C, Campobasso N, Gesualdo L, Schena FP. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 2004; 66: 1570-1577.
15. Maya ID, Maddela P, Barker J, Allon M. Percutaneous renal biopsy: comparison of blind and real-time ultrasound-guided technique. Semin Dial. 2007; 20: 355-358.
16. Hergesell O, Felten H, Andrassy K, Kuhn K, Ritz E. Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1,090 consecutive cases. Nephrol Dial Transplant. 1998; 13: 975-977.
17. Katopodis KP, Katsios CG, Koliousi EL, Nastos DS, Siamopoulos KC. Life-threatening hemorrhage from abdominal aorta following a percutaneous renal biopsy. Clin Nephrol. 2006; 65: 446-448.
18. Stiles KP, Hill C, LeBrun CJ, Reinmuth B, Yuan CM, Abbott KC. The impact of bleeding times on major complication rates after percutaneous realtime ultrasound-guided renal biopsies. J Nephrol. 2001; 14: 275-279.
19. Lin WC, Yang Y, Wen YK, Chang CC. Outpatient versus inpatient renal biopsy: a retrospective study. Clin Nephrol. 2006; 66: 17-24.
20. Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Neph. 2004; 15: 142-147.
21. Capitanini A, Tavolaro A, Rosellini M, Rossi A. Wunderlich syndrome during antiplatelet drug therapy. Clin Nephrol. 2009; 71: 342-344.